Literature DB >> 33566881

ANTHROPOMETRIC AND DIETARY ASSESSMENT OF PATIENTS WITH GLYCOGENOSIS TYPE I.

Natália Bauab Jorge1, Adriana Maria Alves de Tommaso1, Gabriel Hessel1.   

Abstract

OBJECTIVE: To perform anthropometric and dietary evaluation of patients with glycogenosis type Ia and Ib.
METHODS: This cross-sectional study is composed of a sample of 11 patients with glycogenosis divided into two subgroups according to the classification of glycogenosis (type Ia=5 and type Ib=6), aged between 4 and 20 years. The analyzed anthropometric variables were weight, height, body mass index, and measures of lean and fat body mass, which were compared with reference values. For dietary assessment, a food frequency questionnaire was used to calculate energy and macronutrients intake as well as the amount of raw cornstarch consumed. Mann-Whitney U test and Fisher's exact test were performed, considering a significance level of 5%.
RESULTS: Patients ingested raw cornstarch in the amount of 0.49 to 1.34 g/kg/dose at a frequency of six times a day, which is lower than recommended (1.75-2.50 g/kg/dose, four times a day). The amount of energy intake was, on average, 50% higher than energy requirements; however, carbohydrate intake was below the adequacy percentage in 5/11 patients. Short stature was found in 4/10 patients; obesity, in 3/11; and muscle mass deficit, in 7/11. There were no statistical differences between the subgroups.
CONCLUSIONS: In patients with glycogenosis type I, there was deficit in growth and muscle mass, but no differences were found between the subgroups (Ia and Ib). Although the diet did not exceed the adequacy of carbohydrates, about 1/3 of the patients presented obesity, probably due to higher energy intake.

Entities:  

Year:  2021        PMID: 33566881      PMCID: PMC7875543          DOI: 10.1590/1984-0462/2021/39/2020046

Source DB:  PubMed          Journal:  Rev Paul Pediatr        ISSN: 0103-0582


  24 in total

1.  [Glycogenosis type I]

Authors:  C V Reis; F J Penna; M C Oliveira; M L Roquete
Journal:  J Pediatr (Rio J)       Date:  1999 Jul-Aug       Impact factor: 2.197

2.  Amelioration of proximal renal tubular dysfunction in type I glycogen storage disease with dietary therapy.

Authors:  Y T Chen; J I Scheinman; H K Park; R A Coleman; C R Roe
Journal:  N Engl J Med       Date:  1990-08-30       Impact factor: 91.245

3.  The growth hormone-insulin-like growth factor axis in glycogen storage disease type 1: evidence of different growth patterns and insulin-like growth factor levels in patients with glycogen storage disease type 1a and 1b.

Authors:  Daniela Melis; Rosario Pivonello; Giancarlo Parenti; Roberto Della Casa; Mariacarolina Salerno; Francesca Balivo; Pasquale Piccolo; Carolina Di Somma; Annamaria Colao; Generoso Andria
Journal:  J Pediatr       Date:  2009-12-21       Impact factor: 4.406

Review 4.  Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I).

Authors:  Jan Peter Rake; Gepke Visser; Philippe Labrune; James V Leonard; Kurt Ullrich; G Peter A Smit
Journal:  Eur J Pediatr       Date:  2002-08-24       Impact factor: 3.183

5.  Type I glycogen storage disease: favourable outcome on a strict management regimen avoiding increased lactate production during childhood and adolescence.

Authors:  Gerhard Däublin; Bernd Schwahn; Udo Wendel
Journal:  Eur J Pediatr       Date:  2002-08-22       Impact factor: 3.183

6.  Glycogen storage disease type I: clinical and laboratory profile.

Authors:  Berenice L Santos; Carolina F M de Souza; Lavinia Schuler-Faccini; Lilia Refosco; Matias Epifanio; Tatiele Nalin; Sandra M G Vieira; Ida V D Schwartz
Journal:  J Pediatr (Rio J)       Date:  2014-07-11       Impact factor: 2.197

7.  Low bone mass in glycogen storage disease type 1 is associated with reduced muscle force and poor metabolic control.

Authors:  Bernd Schwahn; Frank Rauch; Udo Wendel; Eckhard Schönau
Journal:  J Pediatr       Date:  2002-09       Impact factor: 4.406

Review 8.  Nutrition management in chronic liver disease.

Authors:  Ashish Bavdekar; Sheila Bhave; Anand Pandit
Journal:  Indian J Pediatr       Date:  2002-05       Impact factor: 1.967

9.  Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics.

Authors:  Priya S Kishnani; Stephanie L Austin; Jose E Abdenur; Pamela Arn; Deeksha S Bali; Anne Boney; Wendy K Chung; Aditi I Dagli; David Dale; Dwight Koeberl; Michael J Somers; Stephanie Burns Wechsler; David A Weinstein; Joseph I Wolfsdorf; Michael S Watson
Journal:  Genet Med       Date:  2014-11       Impact factor: 8.822

10.  Bone mineral density in children, adolescents and adults with glycogen storage disease type Ia: a cross-sectional and longitudinal study.

Authors:  J P Rake; G Visser; D Huismans; S Huitema; E van der Veer; D A Piers; G P A Smit
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.750

View more
  1 in total

1.  Glycogen storage disease type 1a in the Ohio Amish.

Authors:  Ethan M Scott; Olivia K Wenger; Elizabeth Robinson; Kristina Colling; Miraides F Brown; Jennifer Hershberger; Kadakkal Radhakrishnan
Journal:  JIMD Rep       Date:  2022-06-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.